Trial Profile
Effect of Dapagliflozin on myocardial and renal function following aortic valve stenosis intervention
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 05 Jan 2022
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Acute coronary syndromes; Aortic valve stenosis
- Focus Therapeutic Use
- Acronyms DAPAS
- 05 Jan 2022 New trial record